Skip to main content

Table 2 Virologic response results

From: Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis

Follow up time(weeks)

Number of studies

Test of hetergeneity

Analysis model

Results

RR (95% CI)

P-value

  

I2

P

 

LAM + ADV (n/N)

ETV (n/N)

  

12

4

0%

0.72

Fixed effect model

75/140

70/147

1.08[0.87,1.34]

0.51

24

4

0%

0.83

Fixed effect model

101/140

94/145

1.09[0.93,1.26]

0.29

48

4

0%

0.63

Fixed effect model

126/140

116/147

1.14[1.03,1.26]

0.01

96

3

82%

0.003

Randomed effect model

102/106

87/105

1.13[0.93,1.38]

0.23